Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?

Acta Medica Okayama

Volumn 65, Issue 4, 2011, Pages 259-263

  Ogat, Yoshiko ^a,b   Aoe, Keisuke ^a   Hiraki, Akio ^b   Murakami, Kazuo ^a   Kishino, Daizo ^a   Chikamori, Kenichi ^a   Maeda, Tadashi ^a   Ueoka, Hiroshi ^a   Kiura, Katsuyuki ^b   Tanimoto, Mitsune ^b  

^a NATIONAL SANYO HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adenosine deaminase; Lung cancer; Mesothelioma; Pleural effusion; Tuberculosis

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

AGED; ARTICLE; ENZYMOLOGY; EVALUATION; FEMALE; HUMAN; JAPAN; LABORATORY DIAGNOSIS; LUNG TUMOR; MALE; MESOTHELIOMA; METABOLISM; PLEURA EFFUSION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADENOSINE DEAMINASE; AGED; BIOLOGICAL MARKERS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 80052657595     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Medford A and Maskell N: Pleural effusion. Postgrad Med J (2005) 81: 702-710
2. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodorigez Panadero F and Sahn SA: Management of malignant pleural effusions. Eur Respir J (2001) 18: 402-419.
3. Gopi A, Madhavan SM, Sharma SK and Sahn SA: Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest (2007 131: 880-889.
4. Escudero Bueno C, Garcia-Clemente M, Cuesta-Castro B, Molinos-Martin L, Rodriguez-Ramos S, Gonzalez-Panizo A and Martinez-Glez-Rio J: Cytologic and bacteriologic analysis of fluid and pleural biopsy with Cope's needle. Arch Intern Med (1990) 150: 1190-1194.
5. Yew WW, Chan CY, Kwan SY, Cheung SW and French GL: Diagnosis of tuberculous pleural effusion by the detection of tuber-culostearic acid in pleural aspirates. Chest (1991) 100: 1261-1263.
6. Aoe K, Hiraki A, Murakami T, Eda R, Maeda T, Sugi K and Takeyama H: Diagnostic significance of interferon-gamma in tuberculous pleural effusions. Chest (2003) 123: 740-794
7. Hiraki A, Aoe K, Eda R, Maeda T, Murakami T, Sugi K and Takeyama H: Comparison of six biologic markers for diagnosis of tuberculous pleuritis. Chest (2004) 125: 987-989
8. Aoe K, Hiraki A, Maeda T, Murakami T, Yamazaki K, Sugi K and Takeyama H: Soluble receptor-binding cancer antigen expressed on SiSo Cells (RCAS1) in pleural fluid: A potential diagnostic marker for malignant pleural effusion. Chest (2004) 126: 1195-1197
9. Sharma SK and Mohan A: Adenosine deaminase in diagnosis of tuberculosis pleural effusion. Indian J Chest Dis Allied Sci (1996) 38: 69-71
10. Ocana I, Martinez-Vazquez JM, Segura RM, Fernandez-De-Sevilla T and Capdevila JA: Adenosine deaminase in pleural fluids: Test for diagnosis of tuberculous pleural effusion. Chest (1983)84: 51-53
11. Valdes L, San Jose E, Alvarez D, Sarandeses A, Pose A, Chomon B, Alavarez-Dobano JM, Salgueiro M and Rodrigez Suarez JR: Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest (1993) 103: 458-465.
12. Burgess LJ, Maritz FJ, Le Roux I and Taljaard JJ: Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio: increased specificity for the diagnosis of tuberculous pleuritis. Chest (1996) 109: 414-419.
13. Riantawan P, Chaowalit P, Wongsangiem M and Rojanaraweewong P: Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis. Chest (1999) 116: 97-103.
14. Villegas MV, Labrada LA and Saravia NG: Evaluation of poly-merase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuber culosis. Chest (2000) 118: 1355-1364.
15. Maher D and Raviglione MC: The global epidemic of tuberculosis: a World Health Organization perspective; in uberculosis and non-tuberculosis mycobacterial infection, 4th ED, Saunders, Philadelphia (1999) pp 104-115
16. Tuberculosis Surveillance Center, RIT, JATA: Tuberculosis Annual Report 2008 - Series 1. Summary of TB Notification Statistics in 2008. Kekkaku (2009) 10: 603-606.
17. Hiraki A, Aoe K, Matsuo K, Murakami K, Murakami T, Onoda T, Sugi K, Takeyama H and Eda R: Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion. Int J Tuberc Lung Dis (2003) 7: 1172-1177
18. MetzCE: Basic principles of ROC analysis. Semin Nucl Med (1978) 8: 283-298.
19. Lee YC, Rogers JT, Rodriguez RM, Miller KD and Light RW: Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest (2001) 120: 356-361
20. Seibert AF, Haynes J Jr, Middleton R and Bass JB Jr: Tuberculous pleural effusion: Twenty-year experience. Chest (1991) 99: 883-886.
21. Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K and Sera Y: Asbestos-related lung cancer and mesothelioma in Japan. Ind Health (2001) 39: 65-74
22. Kishimoto T, Ozaki S, Kato K, Nishi H and Genba K: Malignant pleural mesothelioma in part of Japan in relationship to asbestos exposure. Ind Health (2004) 42: 435-439.
23. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH and Mentzer SJ: Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg (1999) 117: 54-65.